The impact of COVID, lockdown and subsequent easing on recovery in an ongoing international study of people in recovery from drug addiction

Lead Research Organisation: University of Derby
Department Name: College of Business, Law & Social Sci

Abstract

Evidence suggests that addiction recovery is a complex and long-term journey generally estimated to last approximately five years after completing a detoxification from the addictive substance. In the first year, the likelihood that the person will relapse is around 50-70% and that gradually diminishes so that, after five years of continuous sobriety, the likelihood of relapsing to substance use drops to around 14%.
The recognition that there is a 'recovery pathway' beyond specialist addiction treatment has resulted in the emergence of a science and practice of supporting recovery by assessing what factors support people to achieve this goal and the barriers they are likely to encounter.

For instance, we know that access to recovery housing, to peer support and to twelve-step mutual aid groups (Narcotics Anonymous and Alcoholics Anonymous) have a positive impact, but that other things, like ongoing mental health problems or involvement with the criminal justice system, are likely to have the opposite effect and increase the likelihood of relapse.

This study builds on an ongoing research study that has assessed pathways to addiction recovery in one country with established recovery models (the UK) and two countries who have only recently developed recovery pathways and models (Belgium and the Netherlands). This original study assessed pathways to recovery and what support systems and services participants had used to support their recovery journeys, with a particular focus on how these varied between men and women.

In the original study, there was an initial screening questionnaire followed by two waves of in-depth questionnaires that allowed us to chart changes over time in wellbeing and functioning, with a subset of people in each of the three countries also completing in-depth interviews about their experiences during their recovery journeys.

That study has allowed two important things to emerge - the first is an international team who have worked closely together to develop a knowledge and expertise and, secondly, a strong and trusting relationship with many of the people in recovery who participated in the earlier waves of the study.

The current proposal aims to build on that research and in particular to assess what impact the fear of COVID (or actually contracting COVID) has had on this vulnerable population and how it has affected their recovery journeys and wellbeing. Again, there will be an emphasis on the differences between men and women but this time there will also be a focus on ongoing recovery support and social support. The current study will allow us to assess the impact that COVID has on the wellbeing of a vulnerable and complex group and to assess what the risk factors are for people to relapse or in other ways suffer the adverse effects of COVID.
 
Description The study is a further wave of an existing cohort study of recovery in drug use comparing men and women, people across different durations of recovery at the start of the study and by country - the study assesses recovery participants from the UK, Belgium and the Netherlands.
In terms of study retention, out of 368 participants who completed the baseline questionnaire, 245 further completed both the T1 and T2 questionnaires, giving an overall retention rate of 66.6% across all time points. I.e., 248 of those who completed baseline also completed T2, whilst 3 of those who had not completed T1 did complete the T2 (post-COVID) online survey.
From baseline to T1 follow-up (ie the year prior to COVID and lockdown), 10.4% reported problematic use of illicit or prescribed drugs at follow up. For the subsequent year (the post-COVID year), the number of individuals who did not have a relapse in this year was 225 (90.7% of the retained sample while 23 individuals (9.7%) reported problematic substance use in the previous year. If the definition of relapse is extended to include problematic alcohol use, this number increases to 36 (or 14.5% of the retained sample). In other words, although there are caveats around retention and drop-out, drug relapse appears lower during the COVID window than in the previous year, but with a slightly higher rate if problematic alcohol use is included.
There was also a gender effect such that, while women were marginally less likely to report problem drug use in the last year (8.8% compared to 9.6% in men; x2 = 0.04; non-significant), they were markedly more likely to report problematic use of either drugs or alcohol use (19.8% compared to 11.5% in men ; x2 = 3.21, p=0.07), suggesting that women are more likely to have had a problem with alcohol in the COVID year.
As in previous analyses, there is a clear relationship between the likelihood of relapse and the recovery stage the person was in at the time of study recruitment. In terms of relapsing to drug use in the year of COVID, this happened for 4.5% of those who were in stable recovery at the time of recruitment, 9.2% of those in sustained recovery and 28.6% of those who had started the study in early recovery (x2 = 15.39; p<0.001).
The study also involved a qualitative study as well as a quantitative cohort study. The following key themes emerged from the in-depth interviews:
• Lack of social interactions/connections
• Importance of physical touch
• Impact on community - positive and negative:
• Dreams/impact on mental health
• Using skills learnt in recovery to deal with COVID and lockdown
• Online meetings - positive and negative
• Relapse or thoughts of using
• Substitute addictions
Exploitation Route There is a problem about delivering face to face support during the pandemic and ongoing support needs are not being met. There is the option of online mutual aid support as outlined above, but this is only partially meeting the needs of those who engage. Some community recovery organisations have attempted to address this omission but their funding is insufficient generally and there needs to be much stronger community recovery support for this population who are at risk of both relapse and significant mental health problems. Our findings suggest that people have not generally struggled to access help that they need but that the receipt of online provision has been sub-optimal for some people who feel that online recovery support is 'support without fellowship'.
There is also a major issue with the transition to problem drinking in this population (particularly among female participants) and ongoing challenges for those who were in early recovery at the start of the study. Providing additional support to these populations is a key conclusion
Sectors Communities and Social Services/Policy,Healthcare,Government, Democracy and Justice

 
Description The findings have been requested by OHID as part of their response to the national drug strategy and to the Dame Carol Black Review, and we have also reported the results through Scottish Government Residential Rehabilitation Working Group, that David Best is a member of. I have provided an oral report to the Office of Recovery which is a part of SAMHSA in the US Federal Government Finally, the findings and the interest in this have yielded two further things 1. a website on recovery innovations - https://recoverypathways.squarespace.com 2. it was instrumental in helping to set up the College of Lived Experience Recovery Organisations (CLERO) who are currently influential in shaping lived experience approaches to drug treatment
First Year Of Impact 2021
Sector Communities and Social Services/Policy,Healthcare,Government, Democracy and Justice,Culture, Heritage, Museums and Collections
Impact Types Cultural,Societal,Policy & public services

 
Description This work has been discussed and presented at the UN Congress on Narcotic Drugs by Dr David Patton; and has been discussed with OHID and the Office of National Drug Control Policy by Professor David Best
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
 
Title with partnerships and funding from this project we have developed two new websites - one an interactive engagement process (Recovery Pathways) and the other a Miro board to evidence and champion recovery innovation 
Description We have created an interactive website to disseminate the research outputs and to promote participant engagement and a second site that allows us to use the innovative methods of Photovoice and narrative reporting 
Type Of Material Improvements to research infrastructure 
Year Produced 2021 
Provided To Others? Yes  
Impact available at Https://www.rec-path.org Https://recoverypathways.squarespace.com 
 
Description College of Lived Experience Recovery Organisations 
Organisation Public Health England
Country United Kingdom 
Sector Public 
PI Contribution The study has allowed the PI to be a founding member of the College of Lived Experience Recovery Organisations which has subsequently become highly influential in policy and practice around the role of community recovery organisations in drug treatment systems
Collaborator Contribution David Best (PI on this study) has focused on developing an evidence base for innovation around recovery organisations and this has influenced the policy agenda through presentations to the Dame Carol Black review and the tasks set the CLERO in the recommendations of her report. The group now has more than 100 members committed to a research evidence base and quality standards for addiction recovery
Impact New research and policy collaborations
Start Year 2020
 
Description Key dissemination event as a co-production and the launch of our Recovery Workbook 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Patients, carers and/or patient groups
Results and Impact - Recovery Workbook: The recovery workbook is an innovative attempt to engage with people who participated in the study to make sense of the findings and to promote and disseminate the key findings and messages from the study. This has yielded a diverse range of creative and unique endeavours that create a lasting legacy for the project. The workbook can be accessed at: https://miro.com/app/board/o9J_ls4KMxY=/?invite_link_id=3194026528
Year(s) Of Engagement Activity 2022
 
Description Presentation of the key findings to the Department of Health drug policy group 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Presentation of the findings of the current project and changes from the NIHR study and implications for policy and practice
Year(s) Of Engagement Activity 2022